| UniProt ID | UBE2T_HUMAN | |
|---|---|---|
| UniProt AC | Q9NPD8 | |
| Protein Name | Ubiquitin-conjugating enzyme E2 T | |
| Gene Name | UBE2T | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 197 | |
| Subcellular Localization | Nucleus . Accumulates to chromatin. | |
| Protein Description | Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. Catalyzes monoubiquitination. Involved in mitomycin-C (MMC)-induced DNA repair. Acts as a specific E2 ubiquitin-conjugating enzyme for the Fanconi anemia complex by associating with E3 ubiquitin-protein ligase FANCL and catalyzing monoubiquitination of FANCD2, a key step in the DNA damage pathway. [PubMed: 16916645] | |
| Protein Sequence | MQRASRLKRELHMLATEPPPGITCWQDKDQMDDLRAQILGGANTPYEKGVFKLEVIIPERYPFEPPQIRFLTPIYHPNIDSAGRICLDVLKLPPKGAWRPSLNIATVLTSIQLLMSEPNPDDPLMADISSEFKYNKPAFLKNARQWTEKHARQKQKADEEEMLDNLPEAGDSRVHNSTQKRKASQLVGIEKKFHPDV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 28 | Acetylation | GITCWQDKDQMDDLR CCCCCCCHHHHHHHH | 34.46 | 26051181 | |
| 28 | Ubiquitination | GITCWQDKDQMDDLR CCCCCCCHHHHHHHH | 34.46 | - | |
| 44 | Phosphorylation | QILGGANTPYEKGVF HHHCCCCCCCCCCCE | 27.06 | 29759185 | |
| 46 | Phosphorylation | LGGANTPYEKGVFKL HCCCCCCCCCCCEEE | 28.38 | 29759185 | |
| 48 | Ubiquitination | GANTPYEKGVFKLEV CCCCCCCCCCEEEEE | 55.31 | 21906983 | |
| 48 | Acetylation | GANTPYEKGVFKLEV CCCCCCCCCCEEEEE | 55.31 | 27452117 | |
| 48 | Ubiquitination | GANTPYEKGVFKLEV CCCCCCCCCCEEEEE | 55.31 | 21890473 | |
| 72 | Phosphorylation | PPQIRFLTPIYHPNI CCEEEEECCCCCCCC | 12.62 | - | |
| 91 | Ubiquitination | RICLDVLKLPPKGAW CEEEEHHCCCCCCCC | 59.81 | 21906983 | |
| 91 | Acetylation | RICLDVLKLPPKGAW CEEEEHHCCCCCCCC | 59.81 | 26051181 | |
| 91 | Ubiquitination | RICLDVLKLPPKGAW CEEEEHHCCCCCCCC | 59.81 | 21890473 | |
| 136 | Ubiquitination | SSEFKYNKPAFLKNA CHHHCCCCHHHHHHH | 34.33 | - | |
| 141 | Ubiquitination | YNKPAFLKNARQWTE CCCHHHHHHHHHHHH | 41.95 | - | |
| 156 | Ubiquitination | KHARQKQKADEEEML HHHHHHHHCCHHHHH | 65.91 | 21906983 | |
| 161 | Acetylation | KQKADEEEMLDNLPE HHHCCHHHHHHCCCH | 42.89 | 19608861 | |
| 161 | Ubiquitination | KQKADEEEMLDNLPE HHHCCHHHHHHCCCH | 42.89 | 19608861 | |
| 172 | Phosphorylation | NLPEAGDSRVHNSTQ CCCHHCCCCCCCHHH | 34.97 | 25849741 | |
| 177 | Phosphorylation | GDSRVHNSTQKRKAS CCCCCCCHHHHHHHH | 19.82 | 25627689 | |
| 178 | Phosphorylation | DSRVHNSTQKRKASQ CCCCCCHHHHHHHHH | 43.35 | 25849741 | |
| 180 | Ubiquitination | RVHNSTQKRKASQLV CCCCHHHHHHHHHHH | 56.82 | 21890473 | |
| 182 | Ubiquitination | HNSTQKRKASQLVGI CCHHHHHHHHHHHCC | 60.47 | 21906983 | |
| 184 | Phosphorylation | STQKRKASQLVGIEK HHHHHHHHHHHCCCC | 27.38 | 23401153 | |
| 191 | Ubiquitination | SQLVGIEKKFHPDV- HHHHCCCCCCCCCC- | 59.84 | 21906983 | |
| 191 | Acetylation | SQLVGIEKKFHPDV- HHHHCCCCCCCCCC- | 59.84 | 23749302 | |
| 191 | Ubiquitination | SQLVGIEKKFHPDV- HHHHCCCCCCCCCC- | 59.84 | 21890473 | |
| 191 | Sumoylation | SQLVGIEKKFHPDV- HHHHCCCCCCCCCC- | 59.84 | 28112733 | |
| 192 | Ubiquitination | QLVGIEKKFHPDV-- HHHCCCCCCCCCC-- | 35.79 | - | |
| 192 | Sumoylation | QLVGIEKKFHPDV-- HHHCCCCCCCCCC-- | 35.79 | 28112733 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UBE2T_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBE2T_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| AMFR_HUMAN | AMFR | physical | 19690564 | |
| PCGF2_HUMAN | PCGF2 | physical | 19690564 | |
| RNF4_HUMAN | RNF4 | physical | 19690564 | |
| ARI2_HUMAN | ARIH2 | physical | 19549727 | |
| TRI27_HUMAN | TRIM27 | physical | 19549727 | |
| R144B_HUMAN | RNF144B | physical | 19549727 | |
| LNX2_HUMAN | LNX2 | physical | 19549727 | |
| MARH5_HUMAN | MARCH5 | physical | 19549727 | |
| MGRN1_HUMAN | MGRN1 | physical | 19549727 | |
| RN128_HUMAN | RNF128 | physical | 19549727 | |
| FANCL_HUMAN | FANCL | physical | 16916645 | |
| BRCA1_HUMAN | BRCA1 | physical | 19887602 | |
| VINEX_HUMAN | SORBS3 | physical | 22939629 | |
| FANCL_HUMAN | FANCL | physical | 24623813 | |
| UBE2T_HUMAN | UBE2T | physical | 19111657 | |
| UBE2T_HUMAN | UBE2T | physical | 20061386 | |
| FANCL_HUMAN | FANCL | physical | 25464845 | |
| RACK1_HUMAN | GNB2L1 | physical | 26344197 | |
| PRDX2_HUMAN | PRDX2 | physical | 26344197 | |
| SRA1_HUMAN | SRA1 | physical | 26344197 | |
| UBE2T_HUMAN | UBE2T | physical | 26046368 | |
| FANCL_HUMAN | FANCL | physical | 26046368 | |
| FACD2_HUMAN | FANCD2 | physical | 26046368 | |
| UBE2T_HUMAN | UBE2T | physical | 26149689 | |
| FANCB_HUMAN | FANCB | physical | 28514442 | |
| FP100_HUMAN | C17orf70 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 616435 | Fanconi anemia complementation group T (FANCT) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184, AND MASSSPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184, AND MASSSPECTROMETRY. | |
| Ubiquitylation | |
| Reference | PubMed |
| "Mechanistic insight into site-restricted monoubiquitination of FANCD2by Ube2t, FANCL, and FANCI."; Alpi A.F., Pace P.E., Babu M.M., Patel K.J.; Mol. Cell 32:767-777(2008). Cited for: FUNCTION, INTERACTION WITH FANCL, UBIQUITINATION AT LYS-91 ANDLYS-182, AND MUTAGENESIS OF CYS-86; LYS-91 AND 182-LYS--LYS-191. | |
| "UBE2T is the E2 in the Fanconi anemia pathway and undergoes negativeautoregulation."; Machida Y.J., Machida Y., Chen Y., Gurtan A.M., Kupfer G.M.,D'Andrea A.D., Dutta A.; Mol. Cell 23:589-596(2006). Cited for: FUNCTION, INTERACTION WITH FANCL, UBIQUITINATION AT LYS-91, ANDMUTAGENESIS OF CYS-86. | |